Glenn J. Hanna

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

1.9Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The mutational landscape of early‐ and typical‐onset oral tongue squamous cell carcinoma

Cancer(2020)10.1002/cncr.33309

Top 11%

1.9DataRank

Top 11%52 citations

Zhishan Chen, Daniel L. Faden, Nishant Agrawal, Ryan J. Li, Glenn J. Hanna +11 more

Papers

Driven by 17 papers — median percentile 89. Top paper: “Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial”.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1695

N/A

7.0DataRank · unranked

368 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

The mutational landscape of early‐ and typical‐onset oral tongue squamous cell carcinoma

Cancer(2020)10.1002/cncr.33309

Top 11%

1.9DataRank

Top 11%52 citations

Zhishan Chen, Daniel L. Faden, Nishant Agrawal, Ryan J. Li, Glenn J. Hanna +11 more

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Clinical and Translational Science(2022)10.1111/cts.13387

N/A

0.655DataRank · unranked

16 citations

Aaron R. Hansen, Glenn J. Hanna, Elena Garralda, Haeseong Park, James Strauss +11 more

Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0310

N/A

0DataRank · unranked

28 citations

Michael Diny, Faiza Ali, Jennifer Shin, Gaurav Kumar, Vikas Kumar +9 more

Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma

Radiotherapy and Oncology(2022)10.1016/j.radonc.2022.05.012

N/A

0DataRank · unranked

14 citations

Michael Milligan, Jonathan D. Schoenfeld, Roy B. Tishler, Andrea K. Ng, Phillip M. Devlin +8 more

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1030

N/A

0DataRank · unranked

26 citations

Myung‐Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong +9 more

Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.12.022

N/A

0DataRank · unranked

14 citations

Michelle Sanchez, Elinton Lee, Hans J. Hertzler, Nhi M. Luong, Emanuele Mazzola +17 more

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006721

N/A

0DataRank · unranked

10 citations

Shilpa Bhatia, Brinda Vijaykumar, Qiaomu Tian, Yanbo Sun, Del Leistritz-Edwards +8 more

Data from Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition

(2023)10.1158/1541-7786.c.6545655

N/A

0DataRank · unranked

0 citations

Michael Diny, Faiza Ali, Jennifer H. Shin, Gaurav Kumar, Vikas Kumar +9 more

Data from Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition

(2023)10.1158/1541-7786.c.6545655.v1

N/A

0DataRank · unranked

0 citations

Michael Diny, Faiza Ali, Jennifer H. Shin, Gaurav Kumar, Vikas Kumar +9 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0762

N/A

0DataRank · unranked

11 citations

Thomas E. Stinchcombe, Mrinal M. Gounder, Gregory M. Coté, Glenn J. Hanna, Bradley Sumrall +16 more

Artificial Intelligence Measured Tumor Burden and Pre‐Treatment Circulating Tumor DNA in Human Papilloma Virus‐Associated Oropharynx Cancer

Head & Neck(2025)10.1002/hed.28180

N/A

0DataRank · unranked

4 citations

Zezhong Ye, Jonathan D. Schoenfeld, Homan Mohammadi, Jeffrey P. Guenette, Eleni M. Rettig +3 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

medRxiv(2020)10.1101/2020.03.18.20037846

N/A

0DataRank · unranked

4 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Report of the First International Symposium on NUT Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0591

N/A

0DataRank · unranked

55 citations

Michael L. Cheng, Glenn J. Hanna, Steven G. DuBois, Nicole G. Chau, Christine L. Hann +18 more

Glenn J. Hanna

Indexed papers

Top data-sharing exemplar

Papers